Abstract

BACKGROUND The high mutation rate of the human immunodeficiency virus (HIV) has created a public health challenge because the use of antiretroviral drugs can generate selective pressure that drives resistance in these viruses.OBJECTIVE The aim of this work was to characterise the molecular and epidemiological profile of HIV in Bahia, Brazil.METHODS DNA sequences from regions of HIV gag, pol, and env genes were obtained from previous studies performed in this area between 2002 and 2012. Their genotype and drug-resistance mutations were identified using bioinformatics tools. Clinical and epidemiological data were analysed.FINDINGS Among 263 individuals (46.4% male), 97.5% were asymptomatic and 49.1% were receiving treatment. Most of the individuals were 31 to 40 years old (36.9%) and infected through heterosexual contact (40.7%). The predominant genotype was B (68.1%) followed by BF recombinants (18.6%). Among the individuals infected with either F or BF genotypes, 68.4% were women and 76.8% were infected through heterosexual transmission. The prevalence of associated mutations conferring antiretroviral resistance was 14.2%, with 3.8% of all mutations conferring resistance to protease inhibitors, 9.43% to nucleoside reverse transcriptase inhibitors, and 8.5% to non-nucleoside reverse transcriptase inhibitors. Drug resistance was higher in individuals receiving treatment (26.1%) than in the drug-naïve (4.3%) individuals.MAIN CONCLUSIONS This study will contribute to the understanding and monitoring of HIV epidemic in this Brazilian region.

Highlights

  • The high mutation rate of the human immunodeficiency virus (HIV) has created a public health challenge because the use of antiretroviral drugs can generate selective pressure that drives resistance in these viruses

  • The most prevalent mutation associated with resistance to NNRTIs in this dataset was K103N (2.8%), followed by a: drug naïve individuals only; b: 82.8% of individuals were Antiretroviral drugs (ARVs) experienced; c: 77.2% of individuals were ARV experienced; ARV: antiretroviral drugs; N: total number of patients analysed; NNRTI: non-nucleoside reverse transcriptase inhibitors; NRTI: nucleoside reverse transcriptase inhibitors; protease inhibitors (PIs): protease inhibitor

  • Brazil is a large country with diverse HIV-1 genotype patterns in its geographic regions

Read more

Summary

OBJECTIVE

The aim of this work was to characterise the molecular and epidemiological profile of HIV in Bahia, Brazil. Despite improvements brought about by ARVs in the quality of life and life expectancy of infected individuals, HIV/AIDS is still considered one of the most severe epidemics in the world. To better characterise the HIV/AIDS epidemic in Bahia, the present study used clinical and epidemiological data from HIV-1 infected individuals recruited between 2002 and 2012 to determine population and viral features. This analysis will contribute to the understanding and monitoring of the dissemination of HIV in this Brazilian region. 412 HIV-1 infection in Bahia, Brazil Amanda GM Amaral et al

MATERIALS AND METHODS
RESULTS
B BF BFi C DF F
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call